Diabetes therapy
Intestinal Fructose Metabolism Triggers Glucagon-Like Peptide-1-β-Cell Axis to Prevent Post-Fructose Hyperglycemia
Researchers from Fujita Health University have made a significant discovery in the field of nutritional and metabolic diseases. According to a news report, the team found that fructose ingestion increases circulating glucagon-like peptide-1 (GLP-1) and insulin, which helps to counteract fructose-induced hyperglycemia. The study, published in The Journal of Physiology,